Tejpatta

<h3> Absolute Contraindications of Tejpatta (Cinnamomum tamala) </h3> <h4> 1) On oral anticoagulant / antiplatelet therapy (e.g., warfarin, DOACs, aspirin) </h4> <ul> <li> 🩸</li> <li> Recommendation: Avoid concentrated tejpatta extracts or high-dose supplements if you are taking blood thinners; discuss with your clinician before use.</li> <li> Reasoning: Laboratory and review evidence shows Cinnamomum extracts can inhibit platelet aggregation and affect thromboxane/PAF-related signalling; when combined with anticoagulants or antiplatelet drugs this may raise bleeding risk.</li> <li> Scientific_Study_Title: Targeting the Platelet-Activating Factor Receptor (PAF-R): Antithrombotic and Anti-Atherosclerotic Nutrients</li> <li> Scientific_Study_Authors: Rajendran Harishkumar, Sakshi Hans, Janelle E. Stanton, Andreas M. Grabrucker, Ronan Lordan, Ioannis Zabetakis</li> <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/36297097/</li> <li> Scientific_Study_Excerpt: <p>The review presents evidence that dietary phytochemicals can modulate platelet-activating factor signalling and platelet function. It summarises experimental findings where plant extracts and polar lipids reduce platelet activation and thrombotic pathways; the authors highlight that certain food constituents interfere with COX/LOX and PAF-R mediated signalling leading to reduced thromboxane and platelet aggregation in vitro and in animal models. The review emphasises the potential for dietary agents to have clinically relevant antithrombotic effects and recommends caution and further human studies where concentrated extracts are used alongside anticoagulant medications.</p> <p>In this context, specific Cinnamomum extracts and related constituents are included among dietary agents that can affect platelet-related pathways and therefore could potentiate bleeding when combined with pharmaceutical anticoagulants.</p> </li> </ul> <h4> 2) Concurrent use with glucose-lowering medications (insulin, sulfonylureas, meglitinides) </h4> <ul> <li> 🍬</li> <li> Recommendation: If you are on prescription hypoglycaemic therapy, do not use concentrated tejpatta supplements without medical supervision; monitor blood glucose closely and consider avoiding supplemental/therapeutic doses.</li> <li> Reasoning: Animal and in vitro studies show C. tamala extracts and essential oil lower blood glucose, inhibit carbohydrate-digesting enzymes, and can potentiate glucose lowering - raising the risk of symptomatic hypoglycaemia when used with drugs that lower glucose.</li> <li> Scientific_Study_Title: GC-MS analysis and screening of antidiabetic, antioxidant and hypolipidemic potential of Cinnamomum tamala oil in streptozotocin induced diabetes mellitus in rats</li> <li> Scientific_Study_Authors: Suresh Kumar, Neeru Vasudeva, Sunil Sharma</li> <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/22882757/</li> <li> Scientific_Study_Excerpt: <p>In a streptozotocin-induced diabetic rat model, oral administration of C. tamala oil (100-200 mg/kg) and isolated cinnamaldehyde significantly reduced blood glucose and glycosylated hemoglobin, increased plasma insulin and liver glycogen, and improved antioxidant parameters. Treated animals showed better oral glucose tolerance and reductions in hyperglycaemic markers compared with diabetic controls, with effects comparable to the standard drug glibenclamide in this model.</p> <p>These results indicate biological glucose-lowering activity from C. tamala preparations in vivo, supporting the need for caution when combined with clinical hypoglycaemic medications due to potential additive effects.</p> </li> </ul> <h4> 3) Known allergy to cinnamon or to constituents like cinnamaldehyde / eugenol (skin or oral allergy)</h4> <ul> <li> ⚠️</li> <li> Recommendation: Avoid tejpatta (including culinary and topical use) if you have a documented cinnamon/cinnamaldehyde allergy or history of contact dermatitis from cinnamon-containing products.</li> <li> Reasoning: Cases and patch-test series document delayed allergic contact dermatitis and oral stomatitis from cinnamon aldehydes; C. tamala contains related volatile aldehydes/phenolics capable of provoking similar allergic reactions in sensitised individuals.</li> <li> Scientific_Study_Title: Occupational allergic contact dermatitis from cinnamon including one case from airborne exposure</li> <li> Scientific_Study_Authors: Leena Ackermann, Kristiina Aalto-Korte, Riitta Jolanki, Kristiina Alanko</li> <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/19207380/</li> <li> Scientific_Study_Excerpt: <p>The authors reviewed cases from dermatology clinics and identified six patients with delayed contact allergy to cinnamon; four cases were occupational and one involved airborne exposure causing facial/neck dermatitis. Patch testing implicated cinnamal (cinnamaldehyde derivative) as a principal allergen. Clinical presentations included hand dermatitis in food handlers and airborne facial dermatitis, with reactions confirmed by patch tests.</p> <p>These clinical data show that cinnamaldehyde-containing spices can cause true allergic contact reactions in sensitised people - applicable to related species containing similar volatile aldehydes such as tejpatta.</p> </li> </ul> <h3> Relative Contraindications of Tejpatta (Cinnamomum tamala) </h3> <h4> 1) Pregnancy and breastfeeding - caution / avoid high-dose or concentrated extracts</h4> <ul> <li> 🤰</li> <li> Recommendation: Avoid concentrated tejpatta essential oils or high-dose supplements during pregnancy and lactation; small culinary amounts are typically acceptable but check with your clinician.</li> <li> Reasoning: There is limited reproductive safety data for many concentrated herbal essential oils. Reviews of herbal use in pregnancy emphasise potential embryo-toxic, abortifacient or uterotonic effects for some botanicals and recommend caution when evidence is lacking.</li> <li> Scientific_Study_Title: Is it safe to consume traditional medicinal plants during pregnancy? (systematic review)</li> <li> Scientific_Study_Authors: (review authors - see PubMed entry)</li> <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/33164294/</li> <li> Scientific_Study_Excerpt: <p>Systematic review evidence indicates that many traditional medicinal plants lack adequate safety data during pregnancy and that some plant constituents can cross the placenta or alter hormonal/uterine activity leading to embryotoxic or abortifacient outcomes in preclinical studies. The authors recommend avoiding herbal self-medication during pregnancy in the absence of reliable safety data and advise clinician supervision where necessary.</p> <p>Because C. tamala essential oil contains biologically active volatile compounds and there are no robust human pregnancy safety trials, prudence favours avoiding concentrated preparations during pregnancy and lactation.</p> </li> </ul> <h4> 2) Before surgery or invasive procedures (stop concentrated use several days prior)</h4> <ul> <li> ✂️</li> <li> Recommendation: Stop high-dose tejpatta supplements at least 7-10 days before elective surgery, and tell your surgical/anesthesia team about any herbal use.</li> <li> Reasoning: Herbal agents with antiplatelet or anticoagulant effects can increase perioperative bleeding risk; reviews of herb-warfarin and herb-surgery interactions recommend stopping such products preoperatively.</li> <li> Scientific_Study_Title: Safety Issues of Herb-Warfarin Interactions (review)</li> <li> Scientific_Study_Authors: (review authors - see PubMed entry)</li> <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/38465436/</li> <li> Scientific_Study_Excerpt: <p>Reviews summarise clinical reports and mechanistic studies showing that herbs and concentrated botanical preparations can alter coagulation or interact pharmacodynamically with anticoagulants, producing bleeding events (including post-operative bleeding). They emphasise variability across data sources and recommend that patients on anticoagulants or undergoing surgery avoid or disclose herbal product use and that clinicians query herbal supplements preoperatively.</p> </li> </ul> <h4> 3) Pre-existing hepatic impairment - use cautiously (avoid high doses)</h4> <ul> <li> 🧠⚖️ (liver caution)</li> <li> Recommendation: People with known liver disease should avoid high-dose tejpatta extracts unless supervised by a clinician; dietary culinary use is usually acceptable but monitor liver tests if using concentrated supplements.</li> <li> Reasoning: While C. tamala shows antioxidant and sometimes hepatoprotective signals in some models, concentrated herbal products can in general cause idiosyncratic liver injury in susceptible individuals; prudence is advised when clinical safety data are limited.</li> <li> Scientific_Study_Title: Herbal hepatotoxicity (review)</li> <li> Scientific_Study_Authors: (review authors - see PubMed entry)</li> <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/12016550/</li> <li> Scientific_Study_Excerpt: <p>Comprehensive reviews document cases of herb-induced liver injury across many botanicals and note that some herbal products and concentrated extracts can produce transaminase elevations, cholestasis, and in rare cases acute liver failure. The reviews recommend careful use of concentrated botanicals in patients with pre-existing hepatic disease and call for vigilance and reporting of suspected herb-related liver injury.</p> </li> </ul>